Review article: albumin as a drug—biological effects of albumin unrelated to oncotic pressure

Albumin is the main determinant of plasma oncotic pressure and it plays a pivotal role in modulating the distribution of fluids between compartments. Moreover, it has many other biological properties which may be important not only for its physiological actions but also for its therapeutic effects. Among the non‐oncotic properties are its capacity of molecule transportation and free radical scavenging, its ability to modulate capillar permeability, neutrophil adhesion and activation and its haemostatic effects. The following article reviews these biological effects as well as its structure, synthesis, catabolism and distribution.

[1]  D. Burris,et al.  Human neutrophil activation and increased adhesion by various resuscitation fluids , 2000, Critical care medicine.

[2]  C. Redman.  Biosynthesis of serum proteins and ferritin by free and attached ribosomes of rat liver. , 1969, The Journal of biological chemistry.

[3]  T. King.  On the sulfhydryl group of human plasma albumin. , 1961, The Journal of biological chemistry.

[4]  R. Moggio,et al.  Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients , 1983, Critical care medicine.

[5]  F. Crawford,et al.  A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. , 1985, The Journal of thoracic and cardiovascular surgery.

[6]  H. Parving,et al.  Transcapillary Escape Rate of Albumin and Plasma Volume in Essential Hypertension , 1973, Circulation research.

[7]  S. Kimball,et al.  Hormonal regulation of albumin gene expression in primary cultures of rat hepatocytes. , 1995, The American journal of physiology.

[8]  A. Brix,et al.  Hextend (hetastarch solution) decreases multiple organ injury and xanthine oxidase release after hepatoenteric ischemia-reperfusion in rabbits. , 1997, Critical care medicine.

[9]  R. Strauss,et al.  An international view of hydroxyethyl starches , 1999, Intensive Care Medicine.

[10]  C. Nathan,et al.  Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin) , 1993, The Journal of cell biology.

[11]  J. Ramirez-Vick,et al.  Albumin modulation of paracellular permeability of pig vena caval endothelium shows specificity for pig albumin. , 1993, The American journal of physiology.

[12]  N. Chalasani,et al.  Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. , 2001, Journal of the American Society of Nephrology : JASN.

[13]  W. Shoemaker,et al.  Oxygen transport and utilization in hyperoxia and hypoxia: Relation of conjunctival and transcutaneous oxygen tensions to hemodynamic and oxygen transport variables , 1984, Critical care medicine.

[14]  P. Angood,et al.  Does the addition of albumin to the prime solution in cardiopulmonary bypass affect clinical outcome? A prospective randomized study. , 1989, The Journal of thoracic and cardiovascular surgery.

[15]  W. Maleck,et al.  The Effect of In Vitro Hemodilution with Gelatin, Dextran, Hydroxyethyl Starch, or Ringer’s Solution on Thrombelastograph® , 2000, Anesthesia and analgesia.

[16]  S. Smirnov,et al.  Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth muscle and endothelial cells. , 1998, Circulation research.

[17]  A. Malik,et al.  Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix. , 1993, The American journal of physiology.

[18]  E. Bouskela,et al.  Vascular permeability increase and plasma volume loss induced by endotoxin was attenuated by hypertonic saline with or without dextran. , 1999, Shock.

[19]  B. Halliwell,et al.  Albumin--an important extracellular antioxidant? , 1988, Biochemical pharmacology.

[20]  M. Takagi,et al.  Direct evidence for albumin biosynthesis by membrane bound polysomes in rat liver. , 1968, Biochemical and biophysical research communications.

[21]  T. Menges,et al.  Influence of colloid fluids on polymorphonuclear granulocyte function in vivo , 2001, Acta anaesthesiologica Scandinavica.

[22]  P. Kuppusamy,et al.  Polynitroxyl-albumin (PNA) plus tempol attenuate lung capillary leak elicited by prolonged intestinal ischemia and reperfusion(1). , 2000, Free radical biology & medicine.

[23]  A. Cantin,et al.  Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. , 2000, American journal of respiratory and critical care medicine.

[24]  J. Stamler,et al.  Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Ewert,et al.  Hypertonic saline-dextran improves intestinal perfusion and survival in porcine endotoxin shock , 2000, Critical care medicine.

[26]  J. Stamler,et al.  Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[27]  T. Evans,et al.  Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. , 1998, Clinical science.